← Back to Search
Intestinal Fungi Contribute To Development Of Alcoholic Liver Disease
An-Ming Yang, Tatsuo Inamine, Katrin Hochrath, P. Chen, L. Wang, C. Llorente, S. Bluemel, P. Hartmann, J. Xu, Y. Koyama, T. Kisseleva, Manolito G. Torralba, Kelvin J. Moncera, Karen Beeri, C. Chen, K. Freese, C. Hellerbrand, Serene M. L. Lee, H. Hoffman, W. Mehal, G. García-Tsao, E. Mutlu, A. Keshavarzian, G. Brown, S. Ho, R. Bataller, P. Stärkel, D. Fouts, B. Schnabl
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
Chronic liver disease with cirrhosis is the 12th leading cause of death in the United States, and alcoholic liver disease accounts for approximately half of all cirrhosis deaths. Chronic alcohol consumption is associated with intestinal bacterial dysbiosis, yet we understand little about the contribution of intestinal fungi, or mycobiota, to alcoholic liver disease. Here we have demonstrated that chronic alcohol administration increases mycobiota populations and translocation of fungal &bgr;-glucan into systemic circulation in mice. Treating mice with antifungal agents reduced intestinal fungal overgrowth, decreased &bgr;-glucan translocation, and ameliorated ethanol-induced liver disease. Using bone marrow chimeric mice, we found that &bgr;-glucan induces liver inflammation via the C-type lectin–like receptor CLEC7A on Kupffer cells and possibly other bone marrow–derived cells. Subsequent increases in IL-1&bgr; expression and secretion contributed to hepatocyte damage and promoted development of ethanol-induced liver disease. We observed that alcohol-dependent patients displayed reduced intestinal fungal diversity and Candida overgrowth. Compared with healthy individuals and patients with non–alcohol-related cirrhosis, alcoholic cirrhosis patients had increased systemic exposure and immune response to mycobiota. Moreover, the levels of extraintestinal exposure and immune response correlated with mortality. Thus, chronic alcohol consumption is associated with an altered mycobiota and translocation of fungal products. Manipulating the intestinal mycobiome might be an effective strategy for attenuating alcohol-related liver disease.
This paper references
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
P. Chen (2015)
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.
M. Bartoletti (2014)
Isolation of human hepatocytes by a two-step collagenase perfusion procedure.
Serene M. L. Lee (2013)
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
K. Kobayashi (2002)
Dectin-1 is required for β-glucan recognition and control of fungal infection
P. Taylor (2007)
Invasive aspergillosis in patients with severe alcoholic hepatitis.
T. Gustot (2014)
TLR4 enhances TGF-β signaling and hepatic fibrosis
E. Seki (2007)
Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis
S. Y. Hwang (2013)
The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages1
P. Taylor (2002)
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
S. Brydges (2013)
Colonic microbiome is altered in alcoholism.
E. Mutlu (2012)
Microbial biogeography of wine grapes is conditioned by cultivar, vintage, and climate
N. A. Bokulich (2013)
Review article: fungal microbiota and digestive diseases
Z. Wang (2014)
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.
Heike Steiling (2004)
(1,3)-β-Glucans Activate Both Dectin-1 and NLRP3 Inflammasome in Human Macrophages
Päivi M Kankkunen (2010)
The β-Glucan Receptor Dectin-1 Promotes Lung Immunopathology during Fungal Allergy via IL-22
Lauren M. Lilly (2012)
Role of IRAK-M in Alcohol Induced Liver Injury
Y. Wang (2013)
Spontaneous cryptococcal peritonitis in patients with liver cirrhosis.
W. Park (2006)
Interactions between the intestinal microbiome and liver diseases.
B. Schnabl (2014)
Jejunal microflora in patients with chronic alcohol abuse.
J. Bode (1984)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
T. Kisseleva (2012)
Deficiency of intestinal mucin2 ameliorates experimental alcoholic liver disease in mice
P Hartmann (2013)
Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?
M. Papp (2010)
Report On Alcohol And Health 2014
WHO. Global Statu (2017)
Next Generation Sequencing to Define Prokaryotic and Fungal Diversity in the Bovine Rumen
D. Fouts (2012)
Fungal microbiota dysbiosis in IBD [ published online ahead of print February 3 , 2016 ] . Gut
Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
James J Kozich (2013)
Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria.
H. Maeda (2003)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
R. Lozano (2013)
Evidence that chronic alco
A Keshavarzian (2017)
Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury.
Y. Wang (2011)
C-type lectins in immunity: recent developments
I. M. Dambuza (2015)
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.
L. Wang (2016)
Effect of Kupffer cell inactivation on ethanol-induced protein adducts in the liver.
O. Niemelä (2002)
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.
A. Keshavarzian (2009)
Fungal microbiota dysbiosis in IBD
H. Sokol (2016)
FungiQuant: A broad-coverage fungal quantitative real-time PCR assay
C. Liu (2012)
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.
J. du Plessis (2013)
Mycobiome: Approaches to analysis of intestinal fungi.
J. Tang (2015)
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Keiko Iwaisako (2012)
Decontamination of gnotobiotic mice experimentally monoassociated with Candida albicans.
M. Wagner (1975)
Evidence that chronic alco Downloaded from http://www.jci.org on May 31, 2017
A Keshavarzian (2009)
Striking a balance: fungal commensalism versus pathogenesis.
I. Iliev (2013)
Species-level classification of the vaginal microbiome
Jennifer M. Fettweis (2012)
Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis
I. Iliev (2012)
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Weizhong Li (2006)
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.
D. Fouts (2012)
Gut-liver axis in alcoholic liver disease.
G. Szabo (2015)
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
Arthur W. Yan (2011)
Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature
Atsuko Yamahiro (2016)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
J. Petrášek (2012)
CD-HIT: accelerated for clustering the next-generation sequencing data
L. Fu (2012)
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
S. Chen (2009)
World Health Organization website
The Global Burden of Disease Study
C. Murray (2003)
Improved Selection of Internal Transcribed Spacer-Specific Primers Enables Quantitative, Ultra-High-Throughput Profiling of Fungal Communities
N. A. Bokulich (2013)
Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
A. Standaert-Vitse (2006)
Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
D. Fouts (2012)
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Q. Wang (2007)
Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
P. Chen (2015)
Dectin-1 is required for beta-glucan recognition and control of fungal infection.
P. Taylor (2007)
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
P. Schloss (2009)
Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice
P. Hartmann (2013)
Protection from liver fibro
K Iwaisako (2017)
Global status report on alcohol and health
Point-Counterpoint: β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections
E. Theel (2013)
Protection from liver fibroagonist
K Iwaisako (2012)
Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.
I. Kirpich (2016)
Fungal microbiota dysbiosis in IBD [published online ahead of print February 3, 2016
H Sokol (2015)
Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany
W. Thasler (2004)
Caspase-8 Modulates Dectin-1 and Complement Receptor 3–Driven IL-1β Production in Response to β-Glucans and the Fungal Pathogen, Candida albicans
S. Ganesan (2014)
Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients
An-Ming Yang (2014)
Candida colonisation as a source for candidaemia.
L.N. Miranda (2009)
This paper is referenced by
Alcohol or Gut Microbiota: Who Is the Guilty?
M. Meroni (2019)
Microbiome as a therapeutic target in alcohol-related liver disease.
S. Sarin (2019)
The mammalian mycobiome: A complex system in a dynamic relationship with the host
Ghee Chuan Lai (2019)
Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice
T. Hendrikx (2018)
miRNAs Involved in M1/M2 Hyperpolarization Are Clustered and Coordinately Expressed in Alcoholic Hepatitis
Adam Kim (2019)
Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis
Panomwat Amornphimoltham (2019)
Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
S. Lemoinne (2019)
Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium
Wimonrat Panpetch (2019)
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Gurmehr Brar (2018)
Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes
Michael Kriss (2019)
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
H. Fukui (2019)
Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease
Eric K. Kwong (2020)
Fungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase
R. Shrestha (2017)
The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
Dishen Chen (2019)
Host-microbe interactions: commensal fungi in the gut.
Marissa J Paterson (2017)
The Role of the Mycobiota in the Gut-Liver Axis
María Camila Alvarez-Silva (2019)
Clinical Aspects of Alcoholic Liver Disease
Mads Israelsen (2019)
MicroRNAs in alcoholic liver disease: Recent advances and future applications
T. Xu (2018)
Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
P. Stärkel (2018)
Microbiome of Hepatobiliary Diseases
Y. Kim (2018)
The Role of the Bacterial Microbiota in Alcoholic and Non-alcoholic Fatty Liver Disease
Anne L. Madsen (2019)
Breakthrough invasive fungal infections: Who is at risk?
J. Jenks (2020)
Histopathological and molecular signatures of a mouse model of acute-on-chronic alcoholic liver injury demonstrate concordance with human alcoholic hepatitis.
Shinji Furuya (2018)
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
E. Scarpellini (2020)
Unexplained inflammation in end‐stage kidney disease: Is the combination of enhanced gastrointestinal permeability and reticuloendothelial dysfunction its cause?
O. Swift (2019)
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
P. Puri (2018)
Microbiota, a key player in alcoholic liver disease
A. Cassard (2018)
Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract
B. Zhou (2020)
Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen
Alexander Wree (2019)
Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.
Annika Wahlström (2019)
Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis
S. Krohn (2018)
Study of the alterations in the intestinal and extra-intestinal microbiome in rats and humans throughout the progression of cirrhosis
A. S. Badenas (2018)See more